crossover design when use RSABE with two test products [Design Issues]

posted by Darborn – Japan, 2023-08-22 04:24 (191 d 18:39 ago) – Posting: # 23704
Views: 1,606

Dear all,

Normally we use 2x3x3 or 2x2x4 replicated design for RSABE, but it needs only one test drug.
When design a crossover trial with two test drug (or one ODT given with/without water), I run into confusion about how to give a balanced design for the trial.
Furthermore, which make things even worse, I always get confused by "variance-balanced" and "carryover-balance" design.

I came out with the following design, but I'm not sure if it is suitable to use when analyzed with FDA RSABE approach.

T1  R   T2   R
R   T1  R   T2
T2  R   T1  R
R   T2  R   T1

Thank you!

Edit: Tabulators changed to spaces and BBcoded; see also this post #6[Helmut]

Complete thread:

UA Flag
 Admin contact
22,916 posts in 4,807 threads, 1,646 registered users;
31 visitors (0 registered, 31 guests [including 8 identified bots]).
Forum time: 22:03 CET (Europe/Vienna)

Nothing shocks me. I’m a scientist.    Harrison Ford (as Indiana Jones)

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz